Exercise-, and training-induced upregulation of skeletal muscle fatty acid oxidation are not solely dependent on mitochondrial machinery and biogenesis
Abstract
Regulation of skeletal muscle fatty acid oxidation (FAO) and adaptation to exercise training have long been thought to depend on delivery of fatty acids (FAs) to muscle, their diffusion into muscle, and muscle mitochondrial content and biochemical machinery. However, FA entry into muscle occurs via a regulatable, protein‐mediated mechanism, involving several transport proteins. Among these CD36 is key. Muscle contraction and pharmacological agents induce CD36 to translocate to the cell surface, a response that regulates FA transport, and hence FAO. In exercising CD36 KO mice, exercise duration (−44%), and FA transport (−41%) and oxidation (−37%) are comparably impaired, while carbohydrate metabolism is augmented. In trained CD36 KO mice, training‐induced upregulation of FAO is not observed, despite normal training‐induced increases in mitochondrial density and enzymes. Transfecting CD36 into sedentary WT muscle (+41%), comparable to training‐induced CD36 increases (+44%) in WT muscle, markedly upregulates FAO to rates observed in trained WT mice, but without any changes in mitochondrial density and enzymes. Evidently, in vivo CD36‐mediated FA transport is key for muscle fuel selection and training‐induced FAO upregulation, independent of mitochondrial adaptations. This CD36 molecular mechanism challenges the view that skeletal muscle FAO is solely regulated by muscle mitochondrial content and machinery.
Part of CIRS Nexus · Curated by Lauren Lowenstein, The Biotoxin Lady
Key Biomarkers
References (2)
- Enhanced fatty acid oxidation and FATP4 protein expression after endurance exercise training in human skeletal musclePLoS ONE · 2012
- In vivo, fatty acid translocase (CD36) critically regulates skeletal muscle fuel selection, exercise performance, and training-induced adaptation of fatty acid oxidationJournal of Biological Chemistry · 2012
Related Papers
- Pro-resolving and anti-arthritic properties of the MC1 selective agonist PL8177Frontiers in Immunology · 2022 · 1 shared tag
- Guselkumab (Tremfya)Canadian Journal of Health Technologies · 2023 · 1 shared tag
- Physiological and Pharmacological Roles of PTH and PTHrP in Bone Using Their Shared Receptor, PTH1REndocrine Reviews · 2021 · 1 shared tag
- A Transcriptomic Fingerprint for Parkinson's Disease Found in Patients with Chronic Inflammatory Response Syndrome: Implications for Diagnosis, Treatment and PreventionMedical Research Archives · 2024 · 1 shared tag
- Crosstalk Between the Neuroendocrine System and Bone HomeostasisEndocrine Reviews · 2023 · 1 shared tag
- Inflammation and osteosarcopeniaOsteosarcopenia · 2022 · 1 shared tag